-
1
-
-
0032484574
-
Effects of physicochemical properties and other factors on systemic nasal drug delivery
-
1:CAS:528:DyaK2sXnvFGgsbw%3D
-
Behl CR, Pimplaskar HK, Sileno AP, deMeirelea J, Romeo VD (1998) Effects of physicochemical properties and other factors on systemic nasal drug delivery. Adv Drug Del Rev 29:89-116
-
(1998)
Adv Drug Del Rev
, vol.29
, pp. 89-116
-
-
Behl, C.R.1
Pimplaskar, H.K.2
Sileno, A.P.3
Demeirelea, J.4
Romeo, V.D.5
-
3
-
-
70449535001
-
Parkinson's disease
-
J.T. Dipiro R.L. Talbert G.C. Yee G.R. Matzke B.G. Wells M.L. Posey (eds) 6 McGraw-Hill New York
-
Chen JJ, Nelson MV, Swope DM (2008) Parkinson's disease. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey ML (eds) Pharmacotherapy: a pathophysiologic approach, 6th edn. McGraw-Hill, New York, pp 977-988
-
(2008)
Pharmacotherapy: A Pathophysiologic Approach
, pp. 977-988
-
-
Chen, J.J.1
Nelson, M.V.2
Swope, D.M.3
-
4
-
-
79958213431
-
Design and evaluation of levodopa methyl ester intranasal delivery systems
-
1:CAS:528:DC%2BC3MXhtFKjtbbE
-
Chun IK, Lee YH, Lee KE, Gwak HS (2011) Design and evaluation of levodopa methyl ester intranasal delivery systems. J Parkinson's Dis 1:101-107
-
(2011)
J Parkinson's Dis
, vol.1
, pp. 101-107
-
-
Chun, I.K.1
Lee, Y.H.2
Lee, K.E.3
Gwak, H.S.4
-
5
-
-
79953167914
-
Pharmacokinetics of levodopa
-
21080186
-
Contin M, Martinelli P (2010) Pharmacokinetics of levodopa. J Neurol 257:S253-S261
-
(2010)
J Neurol
, vol.257
, pp. 253-S261
-
-
Contin, M.1
Martinelli, P.2
-
6
-
-
34248575520
-
Intranasal delivery: Physicochemical and therapeutic aspects
-
1:CAS:528:DC%2BD2sXlsFahu78%3D 17475423
-
Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC (2007) Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 337:1-24
-
(2007)
Int J Pharm
, vol.337
, pp. 1-24
-
-
Costantino, H.R.1
Illum, L.2
Brandt, G.3
Johnson, P.H.4
Quay, S.C.5
-
7
-
-
0014208039
-
Aromatic amino acids and modification of parkinsonism
-
1:CAS:528:DyaF2sXnsVymsQ%3D%3D 5334614
-
Cotzias CG, Van Woert MH, Schiffer LM (1967) Aromatic amino acids and modification of parkinsonism. New Engl J Med 276:374-379
-
(1967)
New Engl J Med
, vol.276
, pp. 374-379
-
-
Cotzias, C.G.1
Van Woert, M.H.2
Schiffer, L.M.3
-
8
-
-
0034811780
-
A pharmacokinetic model to predict the PK interaction of l-dopa and benserazide in rats
-
1:CAS:528:DC%2BD3MXnt1ekt7Y%3D 11587490
-
Grange S, Holford NHG, Guentert TW (2001) A pharmacokinetic model to predict the PK interaction of l-dopa and benserazide in rats. Pharm Res 18:1174-1184
-
(2001)
Pharm Res
, vol.18
, pp. 1174-1184
-
-
Grange, S.1
Holford, N.H.G.2
Guentert, T.W.3
-
9
-
-
85019182765
-
-
Accessed 10 Oct 2013
-
FDA guidance (2013). http://www.fda.gov/downloads/Food/GuidanceRegulation/UCM078741.pdf. Accessed 10 Oct 2013
-
(2013)
FDA Guidance
-
-
-
10
-
-
0019198381
-
Nasal absorption of propranolol from different dosage forms by rats and dogs
-
1:CAS:528:DyaL3MXptVaisw%3D%3D 7463327
-
Hussain A, Hirai S, Bawarshi R (1980) Nasal absorption of propranolol from different dosage forms by rats and dogs. J Pharm Sci 69:1411-1413
-
(1980)
J Pharm Sci
, vol.69
, pp. 1411-1413
-
-
Hussain, A.1
Hirai, S.2
Bawarshi, R.3
-
11
-
-
0034095651
-
Transport of drugs from the nasal cavity to the central nervous system
-
1:CAS:528:DC%2BD3cXksFektLo%3D 10913748
-
Illum L (2000) Transport of drugs from the nasal cavity to the central nervous system. Eur J Pharm Sci 11:1-18
-
(2000)
Eur J Pharm Sci
, vol.11
, pp. 1-18
-
-
Illum, L.1
-
12
-
-
0033795553
-
Enhancement of the systemic and CNS specific delivery of l-dopa by the nasal administration of its water soluble prodrugs
-
1:CAS:528:DC%2BD3cXntVSltbk%3D 11028945
-
Kao HD, Traboulsi A, Itoh S, Dittert L, Hussain A (2000) Enhancement of the systemic and CNS specific delivery of l-dopa by the nasal administration of its water soluble prodrugs. Pharm Res 17:978-984
-
(2000)
Pharm Res
, vol.17
, pp. 978-984
-
-
Kao, H.D.1
Traboulsi, A.2
Itoh, S.3
Dittert, L.4
Hussain, A.5
-
13
-
-
70449521005
-
Pharmacokinetic evaluation and modeling of formulated levodopa nasal delivery systems
-
1:CAS:528:DC%2BD1MXhsVKgsL3P 19804823
-
Kim TK, Kang W, Chun IK, Oh SY, Lee YH, Gwak HS (2009) Pharmacokinetic evaluation and modeling of formulated levodopa nasal delivery systems. Eur J Pharm Sci 38:525-532
-
(2009)
Eur J Pharm Sci
, vol.38
, pp. 525-532
-
-
Kim, T.K.1
Kang, W.2
Chun, I.K.3
Oh, S.Y.4
Lee, Y.H.5
Gwak, H.S.6
-
14
-
-
33749559943
-
Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-l-cysteine as a mucolytic agent
-
1:CAS:528:DC%2BD28XhtVOgt7rK 16989920
-
Matsuyama T, Morita T, Horikiri Y, Yamahara T, Yoshino H (2006) Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-l-cysteine as a mucolytic agent. J Control Release 115:183-188
-
(2006)
J Control Release
, vol.115
, pp. 183-188
-
-
Matsuyama, T.1
Morita, T.2
Horikiri, Y.3
Yamahara, T.4
Yoshino, H.5
-
15
-
-
33646946771
-
Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients
-
16614536 10.1097/00002826-200603000-00001
-
Müller T, Erdmann C, Bremen D, Schmidt WE, Muhlack S, Woitalla D, Goetze O (2006) Impact of gastric emptying on levodopa pharmacokinetics in Parkinson disease patients. Clin Neuropharmacol 29:61-67
-
(2006)
Clin Neuropharmacol
, vol.29
, pp. 61-67
-
-
Müller, T.1
Erdmann, C.2
Bremen, D.3
Schmidt, W.E.4
Muhlack, S.5
Woitalla, D.6
Goetze, O.7
-
16
-
-
0036587778
-
Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson's disease patients experiencing motor fluctuations with levodopa
-
1:CAS:528:DC%2BD38XmtlSqtLY%3D 12207867
-
Okereke CS (2002) Role of integrative pharmacokinetic and pharmacodynamic optimization strategy in the management of Parkinson's disease patients experiencing motor fluctuations with levodopa. J Pharm Pharm Sci 5:146-161
-
(2002)
J Pharm Pharm Sci
, vol.5
, pp. 146-161
-
-
Okereke, C.S.1
-
18
-
-
1342321742
-
The effects of a normal protein diet on Levodopa plasma kinetics in advanced Parkinson's disease
-
15036167 10.1016/j.parkreldis.2003.10.004
-
Simon N, Gantcheva R, Bruguerolle B, Viallet F (2004) The effects of a normal protein diet on Levodopa plasma kinetics in advanced Parkinson's disease. Parkinsonism Relat Disord 10:137-142
-
(2004)
Parkinsonism Relat Disord
, vol.10
, pp. 137-142
-
-
Simon, N.1
Gantcheva, R.2
Bruguerolle, B.3
Viallet, F.4
-
19
-
-
0032876246
-
Mucosal drug delivery using cellulose derivatives as a functional polymer
-
1:CAS:528:DyaK1MXmsV2ru7c%3D 10518641
-
Suzuki Y, Makino Y (1999) Mucosal drug delivery using cellulose derivatives as a functional polymer. J Control Release 62:101-107
-
(1999)
J Control Release
, vol.62
, pp. 101-107
-
-
Suzuki, Y.1
Makino, Y.2
-
20
-
-
85019191446
-
-
U.S. National Library of Medicine Accessed 20 Oct 2013
-
U.S. National Library of Medicine (2013) Compound summary. http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=6047&loc=ec-rcs#x27. Accessed 20 Oct 2013
-
(2013)
Compound Summary
-
-
|